# Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
Canonical URL: https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-announces-pricing-of-4-million-public-offering
Ticker: SNOA
Company: Sonoma Pharmaceuticals
Source: Sonoma Pharmaceuticals
Published: 2026-04-24 13:21 EST
Original Source URL: https://ir.sonomapharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 13:00 EST — [Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution](https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-receives-fda-510-k-clearance-expanding-indications-and-pa-421ff719) — Source: Sonoma Pharmaceuticals
- 2026-06-16 20:15 EST — [Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results](https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-reports-fiscal-year-and-fourth-quarter-2026-financial-res-04e8ed16) — Source: Sonoma Pharmaceuticals
- 2026-04-24 13:21 EST — [Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering](https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-announces-pricing-of-4-million-public-offering) — Source: Sonoma Pharmaceuticals
- 2026-03-24 12:30 EST — [Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart](https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-announces-u-s-retail-launch-of-advanced-burn-relief-hydrogel-in-cvs-and-walmart) — Source: Sonoma Pharmaceuticals
- 2026-03-18 12:30 EST — [Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin](https://biopharmsignal.com/news/SNOA/sonoma-pharmaceuticals-announces-launch-of-new-dermatology-product-line-under-person-and-covey-s-aquanil-brand-for-sensitive-skin) — Source: Sonoma Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)